Cargando…
MiR200-upregulated Vasohibin 2 promotes the malignant transformation of tumors by inducing epithelial-mesenchymal transition in hepatocellular carcinoma
BACKGROUND: Hepatocellular carcinoma (HCC) typically relies on tumor transformation and angiogenesis for its malignant behavior, including growth and metastasis. Previously, we reported that Vasohibin2 (VASH2) is preferentially expressed in hepatocellular carcinoma (HCC) tumor tissues and promotes a...
Autores principales: | Xue, Xiaofeng, Zhang, Ye, Zhi, Qiaoming, Tu, Min, Xu, Yue, Sun, Jie, Wei, Jishu, Lu, Zipeng, Miao, Yi, Gao, Wentao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195883/ https://www.ncbi.nlm.nih.gov/pubmed/25269476 http://dx.doi.org/10.1186/s12964-014-0062-x |
Ejemplares similares
-
Vasohibin-2 promotes proliferation in human breast cancer cells via upregulation of fibroblast growth factor-2 and growth/differentiation factor-15 expression
por: TU, MIN, et al.
Publicado: (2014) -
Vasohibin 2 promotes malignant behaviors of pancreatic cancer cells by inducing epithelial‐mesenchymal transition via Hedgehog signaling pathway
por: Zhang, Ye, et al.
Publicado: (2018) -
Vasohibin‐2 is required for epithelial–mesenchymal transition of ovarian cancer cells by modulating transforming growth factor‐β signaling
por: Norita, Rie, et al.
Publicado: (2017) -
Vasohibin 2 reduces chemosensitivity to gemcitabine in pancreatic cancer cells via Jun proto-oncogene dependent transactivation of ribonucleotide reductase regulatory subunit M2
por: Tu, Min, et al.
Publicado: (2017) -
Vasohibin 2 Decreases the Cisplatin Sensitivity of Hepatocarcinoma Cell Line by Downregulating p53
por: Li, Zhanjun, et al.
Publicado: (2014)